RecruitingNCT06802731

LivQ-box® Parameters in the Diagnosis of Liver Inflammation

A Multicenter Study on the Application of LivQ-box® Parameters in the Diagnosis of Liver Inflammation in Patients with Non-alcoholic Fatty Liver Disease

Sponsor

Wuxi Hisky Medical Technology Co Ltd

Enrollment

365 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Fatty Liver Disease Liver Inflammation

Summary

To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

Patients diagnosed with NAFLD according to The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases;
Age over 18 years old, gender not limited;
Not combined with liver diseases (such as viral hepatitis, drug-induced liver injury, autoimmune liver disease);
Perform iLivTouch examination within ± 14 days of liver pathology examination;
No history of excessive alcohol consumption (converted to ethanol:\<140g/week for males,\<70g/week for females);

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.